Columbus Venture Partners and AskBio launch gene therapy joint venture

AskBio and Columbus Venture Partners have formed Viralgen, a gene therapy joint venture. In addition to funding from AskBio and Columbus Venture Partners, Viralgen, which will be based in San Sebastián, Spain, has secured a "significant" commitment from the Basque Government. No financial terms were disclosed.

17 October 2017•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail